Journal
KOREAN JOURNAL OF INTERNAL MEDICINE
Volume 35, Issue 3, Pages 535-543Publisher
KOREAN ASSOC INTERNAL MEDICINE
DOI: 10.3904/kjim.2020.069
Keywords
Cholangiopancreatography; endoscopic retrograde; Pancreatitis; Anti-inflammatory agents; non-steroidal
Categories
Ask authors/readers for more resources
Acute pancreatitis is the most common and feared adverse event associated with performance of endoscopic retrograde cholangiopancreatography (ERCP). Unremitting effort has been made for over 40 years to minimize the frequency and severity of this complication. Recently, the use of rectal non-steroidal anti-inflammatory drugs ( NSAIDs) have opened a new era for its prevention. This review focuses on the role of NSAIDs in pancreatitis, the pharmacokinetics of these agents, and summarizes the results of clinical trials with rectal NSAIDs alone and combination regimens in the prevention of post-ERCP pancreatitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available